Research Center: Purdue University
Location: A.H. Ismail Center for Preventive and Lifestyle Medicine Lyles-Porter Hall, 715 Clinic Dr, West Lafayette, IN 47907
Lead Researcher: Dr. Chad C. Carroll
IRB: This study has been reviewed and approved by the Purdue Institutional Review Board
About the Study
Are you or a loved one living with type 2 diabetes? Purdue University researchers are conducting a study that may revolutionize our understanding of tendon health in individuals with diabetes. Their team is on a mission to explore the fascinating connections between markers in blood serum and changes in tendon properties. But what’s in it for you?
Imagine a future where researchers can decode the mysteries of tendon degeneration and healing, specifically in diabetic populations. This study holds the key to predicting and diagnosing tendinopathy early, potentially transforming the lives of millions affected by diabetes-related tendon diseases.
If you’re 40 or older, join researchers on this journey towards a healthier, happier future! Together, let’s make strides in understanding, preventing, and treating tendon issues in the diabetes community.
Why Participate?
- Participants may help advance research that may lead to the development of new treatment options for diabetic patients with tendon problems.
- Participants will be compensated up to $75 for participating in this study. In the event of withdrawal from the study, compensation will be prorated based on the number of visits completed.
- Participants will be contributing valuable information that may benefit those with type 2 diabetes in the future.
- Participants will be helping to advance medical research.
Your Rights
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you can withdraw at any time.
- Any information that you provide will be kept strictly confidential, except as required by law.
Who Can Participate?
- Men and women aged 40 and above who are diagnosed with type 2 diabetes
- Must not be pregnant or breastfeeding
- Must not have undergone knee replacement surgery or had an anterior cruciate ligament (ACL) injury (or similar knee procedure)
- Must be able to attend 5-6 study visits at the research site over approximately 1-2 months (4-6 weeks)
- Must not be individuals who have been diagnosed by a physician with liver disease
- Must not be chronic users of NSAIDs and or cyclooxygenase (COX) inhibitors
More Study Details
The study team will explain the research in its entirety but some details are:
- Participants will be asked to fill out and sign a consent form and medical history form, as well as complete a short survey on tendon pain.
- Participants will be asked to follow a 12-hour fast and undergo a blood sample collection.
- Participants will be asked to have patellar tendon assessments, including ultrasound measurements, familiarization with testing procedures, seated strength tests with ultrasound recording, and a patellar tendon strength assessment. Tendon strength assessments will be conducted with participants seated in a rigid chair with the knee joint at 90 degrees of flexion, monitored by an ultrasound probe during maximal efforts. Additionally, an MRI assessment will involve collecting scans of the patellar tendon (knee) and measuring the size of the knee tendon and thigh muscle using MRI.
About the Research Center
Purdue University
Purdue University is a major research institution known for discoveries in science, technology, engineering, math, and beyond. Founded in 1869, the university proudly serves its state as well as the nation and the world. More than 37,000 students from all 50 states and 130 countries, along with some 850 student organizations and Big Ten Boilermaker athletics, make for a lively environment.
Purdue University and Trialfacts are not affiliated.
Trialfacts collaborates closely with the research team to facilitate a smooth flow of participant recruitment for this study at Purdue. Trialfacts operates as an advertising company to promote the study, while Purdue will be the organization that takes overall responsibility for eligible participants and addresses any questions or concerns that may arise.